ArticleScientific reports2026
Impact of alpha-ketoglutarate treatment on enhancing vase life of chrysanthemum by enhancing antioxidant systems and suppressing ethylene biosynthesis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chrysanthemum is a globally valued cut flower with substantial commercial importance; however, its postharvest longevity is often limited by rapid senescence. This study investigated the application of alpha-ketoglutarate (AKG), a cost-effective and environmentally friendly metabolic intermediate, for extending the vase life of cut chrysanthemum flowers. The effects of 5 mM AKG (compared to a 0 mM control) on vase performance, physiological traits, biochemical composition, and the molecular regulation of ethylene biosynthesis were systematically evaluated. Our results demonstrated that 5 mM AKG significantly prolonged vase life by improving water balance and enhancing flower hydration through increased water uptake. The treatment effectively reinforced the antioxidant defense system by increasing the contents of glutathione, ascorbic acid, total phenolics, and flavonoids, while stimulating the activities of catalase (CAT) and superoxide dismutase (SOD). Consequently, AKG inhibited the accumulation of reactive oxygen species (ROS), leading to a marked reduction in malondialdehyde (MDA) levels, electrolyte leakage (EL), and lipoxygenase (LOX) activity. Furthermore, AKG application suppressed ethylene (ETH) production by downregulating the activities of 1-aminocyclopropane-1-carboxylic acid synthase (ACS) and oxidase (ACO), which was further confirmed by the reduced expression of CmACS1 and CmACO1 genes. Collectively, these findings demonstrate that 5 mM AKG represents a sustainable and eco-friendly strategy for enhancing the postharvest quality and longevity of cut chrysanthemums by integrating metabolic stability with hormonal regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.